Cachexia in rheumatoid arthritis

International Journal of Cardiology

Volumn 85, Issue 1, 2002, Pages 89-99

  Walsmith, Joseph ^a   Roubenoff, Ronenn ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cachexia; Exercise; Insulin action; Interleukin 1 ; Physical activity; Protein metabolism; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

ETANERCEPT; INFLIXIMAB; INSULIN RECEPTOR; INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA;

ARTICULAR CARTILAGE; AUTOIMMUNE DISEASE; BONE; CACHEXIA; DRUG EFFICACY; DRUG SAFETY; ENERGY EXPENDITURE; EXERCISE; HUMAN; IMMUNE SYSTEM; JOINT STIFFNESS; MORBIDITY; MORTALITY; MUSCLE ATROPHY; MUSCLE STRENGTH; ONSET AGE; PAIN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; REVIEW; RHEUMATOID ARTHRITIS; SKELETAL MUSCLE; VISCERA;

ARTHRITIS, RHEUMATOID; CACHEXIA; HUMANS;

EID: 0036342406     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00237-1     Document Type: Review

References (56)

1. Epidemiology and prevention of musculoskeletal disorders
2. Rheumatoid arthritis: Epidemiology, etiology, rheumatoid factor, pathology, pathogenesis
3. Humoral mediation of changing body composition during aging and chronic inflammation
4. Cytokine pathways and joint inflammation in rheumatoid arthritis
5. Cytokines in rheumatoid arthritis
6. The expression of tumor necrosis factor-α by human muscle
7. Resistance exercise decreases skeletal muscle tumor necrosis factor-α in frail elderly humans
8. Cytokines and chemokines are both expressed by human myoblasts: Possible relevance for the immune pathogenesis of muscle inflammation
9. Increased interleukin-1β in human skeletal muscle after exercise
10. Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies
11. Detection of tumor necrosis factor-α but not tumor necrosis factor-β in rheumatoid arthritis synovial fluid and serum
12. Peripheral blood and synovial fluid monocyte expression of interleukin-1α and 1β during active rheumatoid arthritis
13. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells
14. Taking mortality in rheumatoid arthritis seriously - Predictive markers, socioeconomic status and comorbidity
15. Long-term outcome of treating rheumatoid arthritis: Results after 20 years
16. Mortality in rheumatoid arthritis
17. The mortality of rheumatoid arthritis
18. Rheumatoid cachexia: Cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation
19. Tumor necrosis factor-α production is associated with less body cell mass in rheumatoid arthritis
20. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states
21. George Clowes' classic paper and the search for 'muscle proteolysis factor'
22. Nervous mimicry of organic diseases
23. Rheumatoid cachexia: Depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor-α
24. A cross-sectional study of muscle strength and mass in 45 to 78 year-old men and women
25. Energy and the maintenance of body cell mass
26. Starvation in man
27. The meaning and measurement of lean body mass
28. Adipose expression of tumor necrosis factor-α: Direct role in obesity linked insulin resistance
29. Tumor necrosis factor-α inhibits signaling from the insulin receptor
30. Protein metabolism and its mediators before and after strength training in aging and chronic inflammation
31. Catabolic effects of high-dose corticosteroids persist despite therapeutic benefit in rheumatoid arthritis
32. Adjuvant arthritis as a model of inflammatory cachexia
33. Inflammatory cachexia induces sarcoactive cytokine gene expression in a rat model of adjuvant arthritis
34. Cytokine gene expression by skeletal muscle in adjuvant arthritis
35. Tumor necrosis factor induces skeletal muscle protein breakdown in rats
36. The role of interleukin-1 in disease
37. Interleukin-1 and tumor necrosis factor do not regulate protein balance in skeletal muscle
38. NF-kB mediates the protein loss induced by TNF-α in differentiated skeletal muscle myotubes
39. Impaired glucose handling in active rheumatoid arthritis: Relationship to the secretion of insulin and counter-regulatory hormones
40. Impaired glucose handling in active rheumatoid arthritis: Effects of corticosteroids and antirheumatic treatment
41. Evidence for peripheral impaired glucose handling in patients with connective tissue diseases
42. Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients
43. The expression of tumor necrosis factor-α in human adipose tissue
44. Interleukin-1β and tumor necrosis factor-α exhibit different metabolic effects in rheumatoid arthritis [RA]
45. Effect of short-term physical training on patients with rheumatoid arthritis
46. Changes in muscle fibre size and physical performance in patients with rheumatoid arthritis after short-term physical training
47. Physical training in rheumatoid arthritis: A controlled long-term study
48. The effect of progressive resistance training in rheumatoid arthritis: Increased strength without changes in energy balance or body composition
49. Effects of progressive resistance training on immune response in aging and chronic inflammation
50. Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor-α
51. Efficacy of low load resistive muscle training in patients with rheumatoid arthritis functional class II and III
52. Effects of detraining subsequent to strength training on neuromuscular function in patients with inflammatory arthritis
53. Dynamic strength training in patients with early rheumatoid arthritis increases muscle strength but not bone mineral density
54. Benefits of exercise for patients with rheumatoid arthritis
55. Safe and effective isokinetic knee extension training in rheumatoid arthritis
56. How vigorously should we exercise our rheumatoid arthritis patients?